Interleukin 17 (IL-17), a highly potent inflammatory cytokine, plays a significant role in autoimmune disorders like rheumatoid arthritis and multiple sclerosis 15 and is linked to the promotion of cancer progression in CRC and other various tumor types 16, 17. This evidence concerns the gene IL17A and rheumatoid arthritis.